Literature DB >> 10498235

Epidemiological study on sleep habits and insomnia of new outpatients visiting general hospitals in Japan.

J Ishigooka1, M Suzuki, S Isawa, H Muraoka, M Murasaki, M Okawa.   

Abstract

A large scale epidemiological survey of sleep habits, specifically for insomnia, was conducted using 6277 new outpatients from 11 general hospitals in Japan. They were requested to answer a questionnaire newly designed for this study, which consisted of 34 questions concerning sociodemographic characteristics, current medical conditions, sleep habits, current or past sleep complaints, symptoms of parasomnia, use of hypnotics/anxiolytics and other aspects of daily life. Insomnia was the focus of analysis using chi2 statistics and, additionally, logistic regression to explore the predictors of insomnia. Bedtime was 23:30 and wake-up time was 6:35 on average, with a mean sleep time of 6.77 h on weekdays. The number of subjects with current sleep complaints was 1276, of which 735 (11.7% of the total sample) had insomnia lasting for 1 month or more. Only 37.6% of those were taking hypnotics and/or anxiolytics. Old age, female sex, neurology, psychiatry, early bedtime, late wake-up time, living alone and dissatisfaction with the bedroom environment for sleep were found to be associated with long-term insomnia. This study helps to provide a framework for further studies using the general population.

Entities:  

Mesh:

Year:  1999        PMID: 10498235     DOI: 10.1046/j.1440-1819.1999.00578.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  9 in total

1.  A prospective questionnaire study in 100 healthy sleepers: non-bothersome forms of recognizable sleep disorders are still present.

Authors:  Birgit Frauscher; Thomas Mitterling; Aleke Bode; Laura Ehrmann; David Gabelia; Marlene Biermayr; Arthur Scott Walters; Werner Poewe; Birgit Högl
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

Review 2.  Insomnia and its treatment in women with breast cancer.

Authors:  Lavinia Fiorentino; Sonia Ancoli-Israel
Journal:  Sleep Med Rev       Date:  2006-09-11       Impact factor: 11.609

3.  Cortical GABA levels in primary insomnia.

Authors:  Peter T Morgan; Edward F Pace-Schott; Graeme F Mason; Erica Forselius; Madonna Fasula; Gerald W Valentine; Gerard Sanacora
Journal:  Sleep       Date:  2012-06-01       Impact factor: 5.849

4.  Age and gender differences in objective sleep properties using large-scale body acceleration data in a Japanese population.

Authors:  Li Li; Toru Nakamura; Junichiro Hayano; Yoshiharu Yamamoto
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

5.  Prevalence of insomnia symptoms and their associated factors in patients treated in outpatient clinics of four general hospitals in Guangzhou, China.

Authors:  Wei Zheng; Xin-Ni Luo; Hai-Yan Li; Xiao-Yin Ke; Qing Dai; Chan-Juan Zhang; Chee H Ng; Gabor S Ungvari; Yu-Tao Xiang; Yu-Ping Ning
Journal:  BMC Psychiatry       Date:  2018-07-18       Impact factor: 3.630

Review 6.  Effectivity of (Personalized) Cognitive Behavioral Therapy for Insomnia in Mental Health Populations and the Elderly: An Overview.

Authors:  Teus Mijnster; Gretha J Boersma; Esther Meijer; Marike Lancel
Journal:  J Pers Med       Date:  2022-06-29

Review 7.  Antidepressants for insomnia in adults.

Authors:  Hazel Everitt; David S Baldwin; Beth Stuart; Gosia Lipinska; Andrew Mayers; Andrea L Malizia; Christopher Cf Manson; Sue Wilson
Journal:  Cochrane Database Syst Rev       Date:  2018-05-14

8.  Influence of Sleep on Quality of Life Among Hospital Nurses.

Authors:  Zahra Zamanian; Kiana Nikeghbal; Farahnaz Khajehnasiri
Journal:  Electron Physician       Date:  2016-01-15

9.  Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetes.

Authors:  Hajime Narisawa; Yoko Komada; Takashi Miwa; Junpei Shikuma; Mamoru Sakurai; Masato Odawara; Yuichi Inoue
Journal:  Neuropsychiatr Dis Treat       Date:  2017-07-18       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.